The pancreatic β cell: Recent insights from human genetics

Trends in Endocrinology and Metabolism

Volumn 25, Issue 8, 2014, Pages 425-434

  Thomsen, Soren K ^a   Gloyn, Anna L ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

Diabetes; GWAS; Human genetics; Pancreatic cell

Indexed keywords

BIOLOGICAL ACTIVITY; CELL FUNCTION; DIABETES MELLITUS; ENDOCRINE FUNCTION; EXOME; GENE FUNCTION; GENE MUTATION; GENE SEQUENCE; GENE STRUCTURE; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; GENETIC REGULATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOME ANALYSIS; GENOTYPE PHENOTYPE CORRELATION; HOMEOSTASIS; HUMAN; HUMAN GENETICS; INSULIN RELEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PHENOTYPE; PRIORITY JOURNAL; REVIEW; TRANSLATION REGULATION; GENETIC VARIATION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; METABOLISM;

DIABETES MELLITUS, TYPE 2; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; INSULIN-SECRETING CELLS;

EID: 84904755484     PISSN: 10432760     EISSN: 18793061     Source Type: Journal    
DOI: 10.1016/j.tem.2014.05.001     Document Type: Review

References (73)

1. Guariguata L., et al. IDF Diabetes Atlas 2013, International Diabetes Federation.
2. Almgren P., et al. Heritability and familiality of type 2 diabetes and related quantitative traits in the Botnia Study. Diabetologia 2011, 54:2811-2819.
3. Hu F.B. Globalization of diabetes: the role of diet, lifestyle, and genes. Diabetes Care 2011, 34:1249-1257.
4. Voight B.F., et al. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat. Genet. 2010, 42:579-589.
5. Morris A.P., et al. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat. Genet. 2012, 44:981-990.
6. Zuk O., et al. Searching for missing heritability: designing rare variant association studies. Proc. Natl. Acad. Sci. U.S.A. 2014, 111:E455-E464.
7. McCulloch L.J., et al. GLUT2 (SLC2A2) is not the principal glucose transporter in human pancreatic beta cells: implications for understanding genetic association signals at this locus. Mol. Genet. Metab. 2011, 104:648-653.
8. Lango Allen H., et al. GATA6 haploinsufficiency causes pancreatic agenesis in humans. Nat. Genet. 2012, 44:20-22.
9. Flanagan S.E., et al. Analysis of transcription factors key for mouse pancreatic development establishes NKX2-2 and MNX1 mutations as causes of neonatal diabetes in man. Cell Metab. 2014, 19:146-154.
10. Ng H.J., Gloyn A.L. Bridging the gap between genetic associations and molecular mechanisms for type 2 diabetes. Curr. Diab. Rep. 2013, 13:778-785.
11. Weedon M.N., et al. Recessive mutations in a distal PTF1A enhancer cause isolated pancreatic agenesis. Nat. Genet. 2014, 46:61-64.
12. Travers M.E., et al. Insights into the molecular mechanism for type 2 diabetes susceptibility at the KCNQ1 locus from temporal changes in imprinting status in human islets. Diabetes 2013, 62:987-992.
13. Pasquali L., et al. Pancreatic islet enhancer clusters enriched in type 2 diabetes risk-associated variants. Nat. Genet. 2014, 46:136-143.
14. Gaulton K.J., et al. A map of open chromatin in human pancreatic islets. Nat. Genet. 2010, 42:255-259.
15. Volkmar M., et al. DNA methylation profiling identifies epigenetic dysregulation in pancreatic islets from type 2 diabetic patients. EMBO J. 2012, 31:1405-1426.
16. Bhandare R., et al. Genome-wide analysis of histone modifications in human pancreatic islets. Genome Res. 2010, 20:428-433.
17. Parker S.C.J., et al. Chromatin stretch enhancer states drive cell-specific gene regulation and harbor human disease risk variants. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:17921-17926.
18. Stitzel M.L., et al. Global epigenomic analysis of primary human pancreatic islets provides insights into type 2 diabetes susceptibility loci. Cell Metab. 2010, 12:443-455.
19. Dayeh T., et al. Genome-wide DNA methylation analysis of human pancreatic islets from type 2 diabetic and non-diabetic donors identifies candidate genes that influence insulin secretion. PLoS Genet. 2014, 10:e1004160.
20. Moran I., et al. Human beta cell transcriptome analysis uncovers lncRNAs that are tissue-specific, dynamically regulated, and abnormally expressed in type 2 diabetes. Cell Metab. 2012, 16:435-448.
21. van de Bunt M., et al. The miRNA profile of human pancreatic islets and beta-cells and relationship to type 2 diabetes pathogenesis. PLoS ONE 2013, 8:e55272.
22. Kameswaran V., et al. Epigenetic regulation of the DLK1-MEG3 microRNA cluster in human type 2 diabetic islets. Cell Metab. 2014, 19:135-145.
23. Nica A.C., et al. Cell-type, allelic, and genetic signatures in the human pancreatic beta cell transcriptome. Genome Res. 2013, 23:1554-1562.
24. Taneera J., et al. A systems genetics approach identifies genes and pathways for type 2 diabetes in human islets. Cell Metab. 2012, 16:122-134.
25. Loven J., et al. Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell 2013, 153:320-334.
26. Whyte W.A., et al. Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell 2013, 153:307-319.
27. Ashcroft F.M., Rorsman P. Diabetes mellitus and the beta cell: the last ten years. Cell 2012, 148:1160-1171.
28. Flanagan S.E., et al. Update of mutations in the genes encoding the pancreatic beta-cell K(ATP) channel subunits Kir6.2 (KCNJ11) and sulfonylurea receptor 1 (ABCC8) in diabetes mellitus and hyperinsulinism. Hum. Mutat. 2009, 30:170-180.
29. De Franco E., et al. GATA6 mutations cause a broad phenotypic spectrum of diabetes from pancreatic agenesis to adult-onset diabetes without exocrine insufficiency. Diabetes 2013, 62:993-997.
30. Catli G., et al. A novel GATA6 mutation leading to congenital heart defects and permanent neonatal diabetes: a case report. Diabetes Metab. 2013, 39:370-374.
31. Bonnefond A., et al. GATA6 inactivating mutations are associated with heart defects and, inconsistently, with pancreatic agenesis and diabetes. Diabetologia 2012, 55:2845-2847.
32. Tutak E., et al. A Turkish newborn infant with cerebellar agenesis/neonatal diabetes mellitus and PTF1A mutation. Genet. Couns. 2009, 20:147-152.
33. Al-Shammari M., et al. A novel PTF1A mutation in a patient with severe pancreatic and cerebellar involvement. Clin. Genet. 2011, 80:196-198.
34. da Silva Xavier G., et al. Animal models of GWAS-identified type 2 diabetes genes. J. Diabetes Res. 2013, 2013:906590.
35. Smith S.B., et al. Rfx6 directs islet formation and insulin production in mice and humans. Nature 2010, 463:775-780.
36. Bonnefond A., et al. Transcription factor gene MNX1 is a novel cause of permanent neonatal diabetes in a consanguineous family. Diabetes Metab. 2013, 39:276-280.
37. Mahajan A. Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nat. Genet. 2014, 46:234-244.
38. Ingelsson E., et al. Detailed physiologic characterization reveals diverse mechanisms for novel genetic loci regulating glucose and insulin metabolism in humans. Diabetes 2010, 59:1266-1275.
39. Dimas A.S., et al. Impact of type 2 diabetes susceptibility variants on quantitative glycemic traits reveals mechanistic heterogeneity. Diabetes 2013, 10.2337/db2313-0949.
40. Le Bacquer O., et al. TCF7L2 rs7903146 impairs islet function and morphology in non-diabetic individuals. Diabetologia 2012, 55:2677-2681.
41. da Silva Xavier G., et al. Abnormal glucose tolerance and insulin secretion in pancreas-specific Tcf7l2-null mice. Diabetologia 2012, 55:2667-2676.
42. Boj S.F., et al. Diabetes risk gene and Wnt effector Tcf7l2/TCF4 controls hepatic response to perinatal and adult metabolic demand. Cell 2012, 151:1595-1607.
43. Rosengren A.H., et al. Reduced insulin exocytosis in human pancreatic beta-cells with gene variants linked to type 2 diabetes. Diabetes 2012, 61:1726-1733.
44. da Silva Xavier G., et al. TCF7L2 regulates late events in insulin secretion from pancreatic islet beta-cells. Diabetes 2009, 58:894-905.
45. Kong A., et al. Parental origin of sequence variants associated with complex diseases. Nature 2009, 462:868-874.
46. Hanson R.L., et al. Strong parent-of-origin effects in the association of KCNQ1 variants with type 2 diabetes in American Indians. Diabetes 2013, 62:2984-2991.
47. Torekov S.S., et al. KCNQ1 Long QT syndrome patients have hyperinsulinemia and symptomatic hypoglycemia. Diabetes 2013, 63:1315-1325.
48. Manolio T.A., et al. Finding the missing heritability of complex diseases. Nature 2009, 461:747-753.
49. Bonnefond A., et al. Rare MTNR1B variants impairing melatonin receptor 1B function contribute to type 2 diabetes. Nat. Genet. 2012, 44:297-301.
50. Flannick J., et al. Loss-of-function mutations in SLC30A8 protect against type 2 diabetes. Nat. Genet. 2014, 46:357-363.
51. Huyghe J.R., et al. Exome array analysis identifies new loci and low-frequency variants influencing insulin processing and secretion. Nat. Genet. 2013, 45:197-201.
52. Steinthorsdottir V., et al. Identification of low-frequency and rare sequence variants associated with elevated or reduced risk of type 2 diabetes. Nat. Genet. 2014, 46:294-298.
53. Prokopenko I., et al. Variants in MTNR1B influence fasting glucose levels. Nat. Genet. 2009, 41:77-81.
54. Lyssenko V., et al. Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion. Nat. Genet. 2009, 41:82-88.
55. Pound L.D., et al. The physiological effects of deleting the mouse SLC30A8 gene encoding zinc transporter-8 are influenced by gender and genetic background. PLoS ONE 2012, 7:e40972.
56. Pound L.D., et al. Deletion of the mouse Slc30a8 gene encoding zinc transporter-8 results in impaired insulin secretion. Biochem. J. 2009, 421:371-376.
57. Lemaire K., et al. Insulin crystallization depends on zinc transporter ZnT8 expression, but is not required for normal glucose homeostasis in mice. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:14872-14877.
58. Wijesekara N., et al. Beta cell-specific Znt8 deletion in mice causes marked defects in insulin processing, crystallisation and secretion. Diabetologia 2010, 53:1656-1668.
59. Nicolson T.J., et al. Insulin storage and glucose homeostasis in mice null for the granule zinc transporter ZnT8 and studies of the type 2 diabetes-associated variants. Diabetes 2009, 58:2070-2083.
60. Davidson H.W., et al. Zinc transporter 8 (ZnT8) and β cell function. Trends Endocrinol. Metab. 2014, 10.1016/j.tem.2014.1003.1008.
61. Georgia S., et al. Cyclin D2 is essential for the compensatory beta-cell hyperplastic response to insulin resistance in rodents. Diabetes 2010, 59:987-996.
62. Flannick J., et al. Assessing the phenotypic effects in the general population of rare variants in genes for a dominant Mendelian form of diabetes. Nat. Genet. 2013, 45:1380-1385.
63. Ravassard P., et al. A genetically engineered human pancreatic beta cell line exhibiting glucose-inducible insulin secretion. J. Clin. Invest. 2011, 121:3589-3597.
64. Hua H., et al. iPSC-derived beta cells model diabetes due to glucokinase deficiency. J. Clin. Invest. 2013, 123:3146-3153.
65. Maehr R., et al. Generation of pluripotent stem cells from patients with type 1 diabetes. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:15768-15773.
66. Shang L., et al. Beta-cell dysfunction due to increased ER Stress in a stem cell model of Wolfram syndrome. Diabetes 2014, 63:923-933.
67. Cong L., et al. Multiplex genome engineering using CRISPR/Cas systems. Science 2013, 339:819-823.
68. Kasowski M., et al. Extensive variation in chromatin states across humans. Science 2013, 342:750-752.
69. Kilpinen H., et al. Coordinated effects of sequence variation on DNA Binding, chromatin structure, and transcription. Science 2013, 342:744-747.
70. McVicker G., et al. Identification of venetic variants that affect histone modifications in human cells. Science 2013, 342:747-749.
71. Rorsman P., Braun M. Regulation of insulin secretion in human pancreatic islets. Annu. Rev. Physiol. 2013, 75:155-179.
72. Coventry A., et al. Deep resequencing reveals excess rare recent variants consistent with explosive population growth. Nat. Commun. 2010, 1:131.
73. Lohmueller K.E., et al. Whole-exome sequencing of 2,000 Danish individuals and the role of rare coding variants in type 2 diabetes. Am. J. Hum. Genet. 2013, 93:1072-1086.